Header Logo

Connection

J. Walz to Predictive Value of Tests

This is a "connection" page, showing publications J. Walz has written about Predictive Value of Tests.
Connection Strength

0.134
  1. Bjerner J, Bratt O, Aas K, Albertsen PC, Foss? SD, Kv?le R, Lilja H, M?ller C, M?ller S, Stensvold A, Thomas O, R?e OD, Vickers A, Walz J, Carlsson SV, Oldenburg J. Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium. Eur Urol. 2024 Jul; 86(1):20-26.
    View in: PubMed
    Score: 0.041
  2. Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K, Fendler WP. 68Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study. J Urol. 2019 12; 202(6):1174-1181.
    View in: PubMed
    Score: 0.031
  3. Tosco L, Laenen A, Briganti A, Gontero P, Karnes RJ, Bastian PJ, Chlosta P, Claessens F, Chun FK, Everaerts W, Gratzke C, Albersen M, Graefen M, Kneitz B, Marchioro G, Salas RS, Tombal B, Van den Broeck T, Van Der Poel H, Walz J, De Meerleer G, Bossi A, Haustermans K, Van Poppel H, Spahn M, Joniau S. The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis. Eur Urol Focus. 2018 04; 4(3):369-375.
    View in: PubMed
    Score: 0.026
  4. Joniau S, Spahn M, Briganti A, Gandaglia G, Tombal B, Tosco L, Marchioro G, Hsu CY, Walz J, Kneitz B, Bader P, Frohneberg D, Tizzani A, Graefen M, van Cangh P, Karnes RJ, Montorsi F, van Poppel H, Gontero P. Pretreatment tables predicting pathologic stage of locally advanced prostate cancer. Eur Urol. 2015 Feb; 67(2):319-25.
    View in: PubMed
    Score: 0.022
  5. Ahyai SA, Graefen M, Steuber T, Haese A, Schlomm T, Walz J, K?llermann J, Briganti A, Zacharias M, Friedrich MG, Karakiewicz PI, Montorsi F, Huland H, Chun FK. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter. Eur Urol. 2008 Apr; 53(4):750-7.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.